A new report from the International Pharmaceutical Federation (FIP) “Focus on Mental Health: The Contribution of the Pharmacist,” was published on Oct. 9, which was World Mental Health Day. Read More »

SilverScript Insurance Company, a CVS Health company, announced the company's new Medicare Prescription Drug Plan options for 2016 this week. Read More »

The Pharmaceutical Care Management Association (PCMA) recently announced that former Nevada Insurance Commissioner Scott Kipper has been appointed as the association's new vice president of state affairs. Read More »

The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb Company’s Opdivo (nivolumab) injection for the treatment of patients with metastatic, non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Read More »

Eli Lilly and Company on Oct. 9 announced it plans to add 30,000 square feet and approximately 50 new jobs to its research and development presence at the Alexandria Center for Life Science in New York City. Read More »

A new initiative of the Center for Medicare & Medicaid Services (CMS) to improve the medication therapy management (MTM) benefit for patients using stand-alone Medicare Part D plans has received backing from the American Pharmacists Association (APhA). Read More »

Over the last few decades, providing HIV testing at community pharmacies and retail clinics has proved to be an effective way to make sure such testing is available to the general public, as community testing increases convenience and affordability. Read More »

The apparently common practice of storing sterile compounded preparations or repackaging sterile pharmaceuticals in drug-administration syringes is an unapproved use of these medical devices, the U.S. Food and Drug Administration said this week. Read More »

OncLive added the US Oncology Network this week to its Strategic Alliance Partnership program, which is dedicated to raising awareness of cancer treatment and research. “The US Oncology Network was created with patients in mind,” Michael Seiden, chief medical officer of the US Oncology Network, said. Read More »

The American Pharmacists Association (APhA) released a statement last week applauding the Centers for Medicare & Medicaid Services’ (CMS) efforts to improve Medicare medication therapy management (MTM) benefits.CMS recently unveiled a new MTM initiative aimed at evaluating the efficacy of offering prescription drug plans certain incentives to help achieve MTM program goals. Read More »

CVS Health said on Friday that it is expanding its partnership with the Arthritis Foundation to help progress advocacy, research and patient support.CVS/specialty, the specialty pharmacy of CVS Health, will be labeled an Arthritis Foundation 'Partner for Better Living' and will be the group's only specialty pharmacy partner. The announcement comes ahead of World Arthritis Day on Monday. Read More »

The Generic Pharmaceutical Association (GPhA) and its Biosimilars Council commended California lawmakers and the governor this week for a new law that gives patients access to more affordable versions of biologic medicines. Read More »

Merck KGaA, Darmstadt, Germany and Pfizer on Wednesday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to avelumab, a treatment for metastatic Merkel cell carcinoma. Read More »

The Centers for Disease Control and Prevention recently released a letter recognizing the role pharmacists play in improving access to vaccines.“Over the last 20 years, pharmacists have played an expanding role in reducing the risk of vaccine-preventable illnesses by increasing the public’s awareness of the importance of vaccines and improving patient access to vaccination services throughout the United States,” Dr. Anne Schuchat, principal deputy director of the CDC, said in the letter. Read More »

After the release of 2016 National Defense Authorization Act Conference Report last week, NACDS President and CEO Steven C. Anderson voiced concern over provisions that disregard recommendations to ensure pharmacy access and choice for TRICARE patients. Read More »

Pfizer Inc. recently announced that it has completed the acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. Read More »

The Generic Pharmaceutical Association (GPhA) and its Biosimilars Council released a statement on Monday saying they believe the Trans-Pacific Partnership agreement will improve worldwide patient access to affordable medicines. Read More »

Teva Pharmaceutical Industries Ltd. on Thursday announced it has entered into definitive agreements to acquire Rimsa, a leading pharmaceutical manufacturing and distribution company in Mexico. Read More »

Pennsylvania’s pharmacy business is strong and continues to grow despite a nationwide economic slowdown, an American Pharmacy News analysis of state records show. Read More »

The U.S. Food and Drug Administration (FDA) granted accelerated approval on Friday for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda, marketed by Merck, works by targeting the cellular pathway known as PD-1/PD-L1, which are proteins found on the body’s immune cells and some cancer cells. Through blocking this pathway, Keytr Read More »